{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T05:41:47Z","timestamp":1720676507017},"reference-count":127,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.lpm.2017.10.005","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T21:45:52Z","timestamp":1510350352000},"page":"1199-1211","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P1","title":["Traitement m\u00e9dical de l\u2019endom\u00e9triose\u00a0: prise en charge de la douleur et de l\u2019\u00e9volution des l\u00e9sions par traitement hormonal et perspectives th\u00e9rapeutiques"],"prefix":"10.1016","volume":"46","author":[{"given":"Sophie","family":"Geoffron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Legendre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emile","family":"Dara\u00ef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Chabbert-Buffet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.lpm.2017.10.005_bib0640","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1000274","article-title":"Clinical practice. Endometriosis","volume":"362","author":"Giudice","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.lpm.2017.10.005_bib0645","first-page":"440","article-title":"Abdominal wall endometriosis following cesarean section: a study of the growth rate of parietal endometriosis implants","volume":"69","author":"Touleimat","year":"2017","journal-title":"Minerva Ginecol"},{"issue":"8","key":"10.1016\/j.lpm.2017.10.005_bib0650","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/resp.12610","article-title":"Clinical characteristics of catamenial and non-catamenial thoracic endometriosis-related pneumothorax","volume":"20","author":"Fukuoka","year":"2017","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.lpm.2017.10.005_bib0655","first-page":"QR04","article-title":"thoracic endometriosis syndrome: a veritable Pandora's box","volume":"10","author":"Nair","year":"2016","journal-title":"J Clin Diagn Res"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib0660","doi-asserted-by":"crossref","DOI":"10.4293\/JSLS.2014.00312","article-title":"Multidisciplinary treatment for thoracic and abdominopelvic endometriosis","volume":"18","author":"Nezhat","year":"2014","journal-title":"JSLS"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.005_bib0665","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13019-016-0462-7","article-title":"Hormonal therapy after the operation for catamenial pneumothorax\u00a0\u2013\u00a0is it always necessary?","volume":"11","author":"Subotic","year":"2016","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.lpm.2017.10.005_bib0670","series-title":"Recommandations pour la pratique clinique\u00a0: prise en charge de l\u2019endom\u00e9triose","author":"CNGOF","year":"2006"},{"issue":"7 Suppl. 2","key":"10.1016\/j.lpm.2017.10.005_bib0675","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1701-2163(16)34589-3","article-title":"Endometriosis: diagnosis and management","volume":"32","author":"Leyland","year":"2010","journal-title":"J Obstet Gynaecol Can"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib0680","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/humrep\/det457","article-title":"ESHRE guideline: management of women with endometriosis","volume":"29","author":"Dunselman","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.lpm.2017.10.005_bib0685","series-title":"Endometriosis: diagnosis and management","author":"NICE","year":"2017"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib0690","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0015-0282(16)55792-6","article-title":"Buserelin acetate in the treatment of pelvic pain associated with minimal and mild endometriosis: a controlled study","volume":"59","author":"Fedele","year":"1993","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib0695","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/aogs.12326","article-title":"Desogestrel-only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: a prospective open-label comparative study","volume":"93","author":"Leone Roberti Maggiore","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.005_bib0700","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0015-0282(16)56039-7","article-title":"A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis","volume":"60","author":"Vercellini","year":"1993","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib0705","first-page":"CD001019","article-title":"Oral contraceptives for pain associated with endometriosis","author":"Davis","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.005_bib0710","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00404-015-3641-1","article-title":"Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review","volume":"292","author":"Zorbas","year":"2015","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib0715","first-page":"CD002122","article-title":"Progestagens and anti-progestagens for pain associated with endometriosis","author":"Brown","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib0720","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/0300060513479865","article-title":"Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis","volume":"41","author":"Lan","year":"2013","journal-title":"J Int Med Res"},{"issue":"13","key":"10.1016\/j.lpm.2017.10.005_bib0725","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1517\/14656566.2014.943734","article-title":"Dienogest in the treatment of endometriosis","volume":"15","author":"Bizzarri","year":"2014","journal-title":"Expert Opin Pharmacother"},{"issue":"12","key":"10.1016\/j.lpm.2017.10.005_bib0730","first-page":"CD008475","article-title":"Gonadotrophin-releasing hormone analogues for pain associated with endometriosis","author":"Brown","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.005_bib0735","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJMoa1700089","article-title":"Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist","volume":"377","author":"Taylor","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.005_bib0740","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijgo.2010.11.015","article-title":"Vaginal danazol for women with rectovaginal endometriosis and pain symptoms persisting after insertion of a levonorgestrel-releasing intrauterine device","volume":"113","author":"Ferrero","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.lpm.2017.10.005_bib0745","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejogrb.2014.10.036","article-title":"Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment","volume":"183","author":"Morotti","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.lpm.2017.10.005_bib0750","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0015-0282(16)57530-X","article-title":"Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis-associated pelvic pain","volume":"63","author":"Hornstein","year":"1995","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.005_bib0755","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.fertnstert.2005.07.1315","article-title":"Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain","volume":"85","author":"Schlaff","year":"2006","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib0760","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0015-0282(03)00794-5","article-title":"Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen","volume":"80","author":"Vercellini","year":"2003","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib0765","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1067\/mob.2000.106817","article-title":"Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: a prospective, randomized trial","volume":"183","author":"Muzii","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.005_bib0770","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.fertnstert.2008.09.052","article-title":"Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial","volume":"93","author":"Seracchioli","year":"2010","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.005_bib0775","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.fertnstert.2009.03.083","article-title":"Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial","volume":"94","author":"Seracchioli","year":"2010","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.lpm.2017.10.005_bib0780","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.fertnstert.2013.07.008","article-title":"Continuous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis: a prospective cohort study","volume":"100","author":"Vlahos","year":"2013","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.lpm.2017.10.005_bib0785","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.fertnstert.2007.08.051","article-title":"Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial","volume":"90","author":"Harada","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.lpm.2017.10.005_bib0790","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejogrb.2015.06.006","article-title":"Effects of low-dose oral contraceptive pill containing drospirenone\/ethinylestradiol in patients with endometrioma","volume":"191","author":"Taniguchi","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"10.1016\/j.lpm.2017.10.005_bib0795","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/09513590.2011.634936","article-title":"A new oral contraceptive regimen for endometriosis management: preliminary experience with 24\/4-day drospirenone\/ethinylestradiol 3mg\/20mcg","volume":"28","author":"Mabrouk","year":"2012","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.005_bib0800","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejogrb.2009.07.003","article-title":"Recurrence rate of endometrioma after laparoscopic cystectomy: a comparative randomized trial between postoperative hormonal suppression treatment or dietary therapy vs. placebo","volume":"147","author":"Sesti","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"10.1016\/j.lpm.2017.10.005_bib0805","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.fertnstert.2007.01.053","article-title":"Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III\u2013IV. A randomized comparative trial","volume":"88","author":"Sesti","year":"2007","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.lpm.2017.10.005_bib0810","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3109\/09513590.2013.819085","article-title":"Oral contraceptive pills for endometriosis after conservative surgery: a systematic review and meta-analysis","volume":"29","author":"Wu","year":"2013","journal-title":"Gynecol Endocrinol"},{"issue":"11","key":"10.1016\/j.lpm.2017.10.005_bib0815","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1093\/humrep\/dep259","article-title":"Postoperative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis","volume":"24","author":"Seracchioli","year":"2009","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.005_bib0820","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ajog.2015.08.074","article-title":"Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and meta-analysis","volume":"214","author":"Muzii","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.lpm.2017.10.005_bib0825","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.fertnstert.2009.01.071","article-title":"Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis","volume":"93","author":"Vercellini","year":"2010","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.005_bib0830","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000337713","article-title":"Postoperative depot medroxyprogesterone acetate versus continuous oral contraceptive pills in the treatment of endometriosis-associated pain: a randomized comparative trial","volume":"74","author":"Cheewadhanaraks","year":"2012","journal-title":"Gynecol Obstet Invest"},{"issue":"5","key":"10.1016\/j.lpm.2017.10.005_bib0835","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/jog.12030","article-title":"Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients","volume":"39","author":"Morelli","year":"2013","journal-title":"J Obstet Gynaecol Res"},{"issue":"Suppl. 1","key":"10.1016\/j.lpm.2017.10.005_bib0840","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/09513590701669583","article-title":"Effective post-laparoscopic treatment of endometriosis with dydrogesterone","volume":"23","author":"Trivedi","year":"2007","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"10.1016\/j.lpm.2017.10.005_bib0845","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0015-0282(16)56991-X","article-title":"A randomized, double-blind, placebo-controlled study of luteal phase dydrogesterone (Duphaston) in women with minimal to mild endometriosis","volume":"62","author":"Overton","year":"1994","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.005_bib0850","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/09513598709082692","article-title":"Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis","volume":"1","author":"Telimaa","year":"1987","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.005_bib0855","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0002-9378(96)70152-7","article-title":"Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis","volume":"175","author":"Vercellini","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.lpm.2017.10.005_bib0860","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejogrb.2014.05.016","article-title":"Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura","volume":"179","author":"Morotti","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.005_bib0865","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejogrb.2010.04.002","article-title":"Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study","volume":"151","author":"Strowitzki","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.005_bib0870","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00404-011-1941-7","article-title":"Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment","volume":"285","author":"Petraglia","year":"2012","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib0875","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.fertnstert.2015.11.016","article-title":"Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study","volume":"105","author":"Vercellini","year":"2015","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib0880","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/humrep\/dep469","article-title":"Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial","volume":"25","author":"Strowitzki","year":"2010","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib0885","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijgo.2012.01.009","article-title":"Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis","volume":"117","author":"Strowitzki","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib0890","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.fertnstert.2007.12.080","article-title":"Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis\u00a0\u2013\u00a0a randomized, double-blind, multicenter, controlled trial","volume":"91","author":"Harada","year":"2009","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.lpm.2017.10.005_bib0895","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1447-0756.2009.01076.x","article-title":"Long-term use of dienogest for the treatment of endometriosis","volume":"35","author":"Momoeda","year":"2009","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.lpm.2017.10.005_bib0900","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2147\/IJWH.S77202","article-title":"Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program","volume":"7","author":"Strowitzki","year":"2015","journal-title":"Int J Womens Health"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.005_bib0905","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.contraception.2008.07.017","article-title":"Implanon versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis\u00a0\u2013\u00a0a pilot study","volume":"79","author":"Walch","year":"2009","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.005_bib0910","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.contraception.2009.08.003","article-title":"Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue","volume":"81","author":"Ferreira","year":"2010","journal-title":"Contraception"},{"issue":"8","key":"10.1016\/j.lpm.2017.10.005_bib0915","first-page":"637","article-title":"Enlarged ovarian follicles in users of a levonorgestrel-releasing intrauterine system and contraceptive implant","volume":"48","author":"Bahamondes","year":"2003","journal-title":"J Reprod Med"},{"issue":"4","key":"10.1016\/j.lpm.2017.10.005_bib0920","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1469-0705.2002.00805.x","article-title":"Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy","volume":"20","author":"Inki","year":"2002","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.lpm.2017.10.005_bib0925","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.contraception.2005.12.012","article-title":"Ovarian cysts in users of Implanon and Jadelle subdermal contraceptive implants","volume":"73","author":"Hidalgo","year":"2006","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.lpm.2017.10.005_bib0930","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.fertnstert.2015.08.026","article-title":"Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis","volume":"104","author":"Koga","year":"2015","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.lpm.2017.10.005_bib0935","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/aogs.12633","article-title":"Gonadotrophin-releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multicenter randomized trial","volume":"94","author":"Granese","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.005_bib0940","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejogrb.2006.08.002","article-title":"Use of a progestogen-only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis","volume":"135","author":"Razzi","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.lpm.2017.10.005_bib0945","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/humrep\/det041","article-title":"Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: effect on sexual functioning, psychological status and health-related quality of life","volume":"28","author":"Vercellini","year":"2013","journal-title":"Hum Reprod"},{"issue":"12","key":"10.1016\/j.lpm.2017.10.005_bib0950","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1093\/humrep\/des313","article-title":"Surgical versus medical treatment for endometriosis-associated severe deep dyspareunia: I. Effect on pain during intercourse and patient satisfaction","volume":"27","author":"Vercellini","year":"2012","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.005_bib0955","first-page":"CD005072","article-title":"Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery","author":"Abou-Setta","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib0960","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/AOG.0b013e31824264c3","article-title":"Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial","volume":"119","author":"Tanmahasamut","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.005_bib0965","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.fertnstert.2010.08.042","article-title":"Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue","volume":"95","author":"Bayoglu Tekin","year":"2011","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.lpm.2017.10.005_bib0970","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.fertnstert.2006.12.077","article-title":"Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis","volume":"88","author":"Razzi","year":"2007","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.lpm.2017.10.005_bib0975","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0015-0282(98)00019-3","article-title":"Effects of triptorelin versus placebo on the symptoms of endometriosis","volume":"69","author":"Bergqvist","year":"1998","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.lpm.2017.10.005_bib0980","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1067\/mob.2000.106846","article-title":"Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: a double-blind, randomized, placebo-controlled trial","volume":"182","author":"Miller","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.lpm.2017.10.005_bib0985","first-page":"413","article-title":"Nafarelin vs. leuprolide acetate depot for endometriosis. Changes in bone mineral density and vasomotor symptoms. Nafarelin Study Group","volume":"42","author":"Agarwal","year":"1997","journal-title":"J Reprod Med"},{"key":"10.1016\/j.lpm.2017.10.005_bib0990","first-page":"253","article-title":"A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group","volume":"323","author":"Dawood","year":"1990","journal-title":"Prog Clin Biol Res"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib0995","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0015-0282(16)60543-5","article-title":"Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative study","volume":"51","author":"Dmowski","year":"1989","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.005_bib1000","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0002-9378(88)90128-7","article-title":"Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis","volume":"158","author":"Lemay","year":"1988","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.lpm.2017.10.005_bib1005","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.fertnstert.2006.11.044","article-title":"The levonorgestrel-releasing intrauterine system and endometriosis staging","volume":"87","author":"Gomes","year":"2007","journal-title":"Fertil Steril"},{"issue":"7","key":"10.1016\/j.lpm.2017.10.005_bib1010","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/humrep\/deh869","article-title":"Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis","volume":"20","author":"Petta","year":"2005","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.lpm.2017.10.005_bib1015","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/humrep\/deh250","article-title":"One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial","volume":"19","author":"Fernandez","year":"2004","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.lpm.2017.10.005_bib1020","first-page":"CD001297","article-title":"Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density","author":"Sagsveen","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib1025","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00404-014-3230-8","article-title":"Clinical efficacy of add-back therapy in treatment of endometriosis: a meta-analysis","volume":"290","author":"Wu","year":"2014","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib1030","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/AOG.0000000000000964","article-title":"Hormonal add-back therapy for females treated with gonadotropin-releasing hormone agonist for endometriosis: a randomized controlled trial","volume":"126","author":"DiVasta","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.005_bib1035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jpag.2016.02.008","article-title":"The effects of gonadotropin-releasing hormone agonist combined with add-back therapy on quality of life for adolescents with endometriosis: a randomized controlled trial","volume":"30","author":"Sadler Gallagher","year":"2017","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.005_bib1040","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejogrb.2006.10.034","article-title":"A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III\u2013IV endometriosis","volume":"136","author":"Loverro","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"10.1016\/j.lpm.2017.10.005_bib1045","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/jcph.485","article-title":"Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial","volume":"55","author":"Gong","year":"2015","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib1050","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00404-012-2581-2","article-title":"Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies","volume":"287","author":"Ferrero","year":"2013","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.005_bib1055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0412.2012.01470.x","article-title":"Long-term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta-analysis","volume":"92","author":"Vercellini","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"10","key":"10.1016\/j.lpm.2017.10.005_bib1060","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3109\/09513590.2014.929653","article-title":"Effects of long-term postoperative oral contraceptive use for the prevention of endometrioma recurrence on bone mineral density in young women","volume":"30","author":"Lee","year":"2014","journal-title":"Gynecol Endocrinol"},{"issue":"12","key":"10.1016\/j.lpm.2017.10.005_bib1065","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1093\/humrep\/dep297","article-title":"Postoperative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision","volume":"24","author":"Takamura","year":"2009","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.lpm.2017.10.005_bib1070","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ajog.2007.11.010","article-title":"Postoperative oral contraceptive exposure and risk of endometrioma recurrence","volume":"198","author":"Vercellini","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.005_bib1075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.fertnstert.2008.09.052","article-title":"Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial","volume":"93","author":"Seracchioli","year":"2008","journal-title":"Fertil Steril"},{"issue":"12","key":"10.1016\/j.lpm.2017.10.005_bib1080","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1093\/humrep\/deq279","article-title":"Postoperative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence","volume":"25","author":"Lee","year":"2010","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.005_bib1085","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jmig.2010.11.004","article-title":"Oral estroprogestins after laparoscopic surgery to excise endometriomas: continuous or cyclic administration? Results of a multicenter randomized study","volume":"18","author":"Muzii","year":"2011","journal-title":"J Minim Invasive Gynecol"},{"issue":"4","key":"10.1016\/j.lpm.2017.10.005_bib1090","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00404-013-2841-9","article-title":"Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference?","volume":"288","author":"Cucinella","year":"2013","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.005_bib1095","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/aogs.12294","article-title":"Postoperative levonorgestrel-releasing intrauterine system versus oral contraceptives after gonadotropin-releasing hormone agonist treatment for preventing endometrioma recurrence","volume":"93","author":"Cho","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"10.1016\/j.lpm.2017.10.005_bib1100","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0015-0282(01)03270-8","article-title":"Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study","volume":"77","author":"Cosson","year":"2002","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib1105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1479-828X.2010.01152.x","article-title":"Levonorgestrel-releasing intrauterine system (Mirena) and Depot medroxyprogesterone acetate (Depoprovera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised controlled trial","volume":"50","author":"Wong","year":"2010","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.005_bib1110","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.fertnstert.2007.11.027","article-title":"Impact of GnRH agonist treatment on recurrence of ovarian endometriomas after conservative laparoscopic surgery","volume":"91","author":"Jee","year":"2009","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.005_bib1115","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.mce.2012.02.021","article-title":"The imminent dawn of SPRMs in obstetrics and gynecology","volume":"358","author":"Chabbert-Buffet","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.005_bib1120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0015-0282(16)58022-4","article-title":"Treatment of endometriosis with the antiprogesterone mifepristone (RU486)","volume":"65","author":"Kettel","year":"1996","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.lpm.2017.10.005_bib1125","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0002-9378(98)70316-3","article-title":"Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486)","volume":"178","author":"Kettel","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.lpm.2017.10.005_bib1130","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1093\/oxfordjournals.humrep.a135900","article-title":"Effects of the progesterone antagonists onapristone (ZK 98 299) and ZK 136 799 on surgically induced endometriosis in intact rats","volume":"10","author":"Stoeckemann","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.lpm.2017.10.005_bib1135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.prp.2016.10.010","article-title":"Histomorphological changes in endometriosis in a patient treated with ulipristal: a case report","volume":"213","author":"Bateman","year":"2017","journal-title":"Pathol Res Pract"},{"issue":"11","key":"10.1016\/j.lpm.2017.10.005_bib1140","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1177\/1933719114549848","article-title":"Elagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral density","volume":"21","author":"Carr","year":"2014","journal-title":"Reprod Sci"},{"key":"10.1016\/j.lpm.2017.10.005_bib1145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/nyas.12411","article-title":"Aromatase and endometriosis: estrogens play a role","volume":"1317","author":"Ferrero","year":"2014","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"10.1016\/j.lpm.2017.10.005_bib1150","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/molehr\/gap068","article-title":"MicroRNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis","volume":"15","author":"Burney","year":"2009","journal-title":"Mol Hum Reprod"},{"issue":"4","key":"10.1016\/j.lpm.2017.10.005_bib1155","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.fertnstert.2005.04.059","article-title":"Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study","volume":"84","author":"Hefler","year":"2005","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.005_bib1160","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00404-010-1599-6","article-title":"A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis","volume":"284","author":"Alborzi","year":"2010","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.005_bib1165","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.fertnstert.2005.02.018","article-title":"Anastrazole and oral contraceptives: a novel treatment for endometriosis","volume":"84","author":"Amsterdam","year":"2005","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.005_bib1170","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/humrep\/deh035","article-title":"The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial","volume":"19","author":"Soysal","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.lpm.2017.10.005_bib1175","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejogrb.2013.11.030","article-title":"Norethisterone acetate versus norethisterone acetate combined with letrozole for the treatment of ovarian endometriotic cysts: a patient preference study","volume":"174","author":"Ferrero","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib1180","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.fertnstert.2006.12.027","article-title":"Letrozole and norethisterone acetate in rectovaginal endometriosis","volume":"88","author":"Remorgida","year":"2007","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib1185","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1479-828X.2007.00722.x","article-title":"Letrozole and desogestrel-only contraceptive pill for the treatment of stage IV endometriosis","volume":"47","author":"Remorgida","year":"2007","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.005_bib1190","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejogrb.2010.02.023","article-title":"Letrozole and norethisterone acetate in colorectal endometriosis","volume":"150","author":"Ferrero","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.lpm.2017.10.005_bib1195","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.fertnstert.2003.09.029","article-title":"Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study","volume":"81","author":"Ailawadi","year":"2004","journal-title":"Fertil Steril"},{"issue":"12","key":"10.1016\/j.lpm.2017.10.005_bib1200","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/humrep\/dep302","article-title":"Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis","volume":"24","author":"Ferrero","year":"2009","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib1205","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.fertnstert.2012.07.1120","article-title":"Pharmacologic therapies in endometriosis: a systematic review","volume":"98","author":"Soares","year":"2012","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.005_bib1210","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/01.AOG.0000297307.35024.b5","article-title":"Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial","volume":"111","author":"Stratton","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib1215","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1056\/NEJMra0804690","article-title":"Endometriosis","volume":"360","author":"Bulun","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.lpm.2017.10.005_bib1220","first-page":"1621","article-title":"Immunolocalization and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells","volume":"82","author":"Hornung","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib1225","first-page":"1118","article-title":"Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis","volume":"81","author":"Tseng","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.lpm.2017.10.005_bib1230","first-page":"CD008088","article-title":"Anti-TNF-alpha treatment for pelvic pain associated with endometriosis","author":"Lu","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.lpm.2017.10.005_bib1235","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/humrep\/den177","article-title":"Anti-TNF-alpha treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial","volume":"23","author":"Koninckx","year":"2008","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.lpm.2017.10.005_bib1240","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/humupd\/dms026","article-title":"Anti-angiogenic treatment strategies for the therapy of endometriosis","volume":"18","author":"Laschke","year":"2012","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.lpm.2017.10.005_bib1245","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3892\/br.2015.447","article-title":"Association between matrix metalloproteinase-2 and matrix metalloproteinase-9 polymorphisms and endometriosis: a systematic review and meta-analysis","volume":"3","author":"Xin","year":"2015","journal-title":"Biomed Rep"},{"issue":"5","key":"10.1016\/j.lpm.2017.10.005_bib1250","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/humupd\/dmt024","article-title":"The role of the peritoneum in the pathogenesis of endometriosis","volume":"19","author":"Young","year":"2013","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.lpm.2017.10.005_bib1255","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1177\/1933719111424453","article-title":"Valproic acid and progestin inhibit lesion growth and reduce hyperalgesia in experimentally induced endometriosis in rats","volume":"19","author":"Liu","year":"2012","journal-title":"Reprod Sci"},{"key":"10.1016\/j.lpm.2017.10.005_bib1260","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12958-016-0154-0","article-title":"Tranylcypromine, a lysine-specific demethylase 1 (LSD1) inhibitor, suppresses lesion growth and improves generalized hyperalgesia in mouse with induced endometriosis","volume":"14","author":"Sun","year":"2016","journal-title":"Reprod Biol Endocrinol"},{"issue":"12","key":"10.1016\/j.lpm.2017.10.005_bib1265","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1177\/1933719113488450","article-title":"The expression of histone deacetylase 1, but not other class I histone deacetylases, is significantly increased in endometriosis","volume":"20","author":"Samartzis","year":"2013","journal-title":"Reprod Sci"},{"issue":"1","key":"10.1016\/j.lpm.2017.10.005_bib0635","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.fertnstert.2006.11.009","article-title":"A pilot study on the off-label use of valproic acid to treat adenomyosis","volume":"89","author":"Liu","year":"2008","journal-title":"Fertil Steril"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498217304542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498217304542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T00:00:20Z","timestamp":1535241620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498217304542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":127,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0755498217304542"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2017.10.005","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traitement m\u00e9dical de l\u2019endom\u00e9triose\u00a0: prise en charge de la douleur et de l\u2019\u00e9volution des l\u00e9sions par traitement hormonal et perspectives th\u00e9rapeutiques","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2017.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}